2160 Federal Register / Vol. 75, No. 9 / Thursday, January 14, 2010 / Notices 

section 337 of the Tariff Act of 1930, as 

amended, 19 U.S.C. 1337 (‘‘section 

337’’). 

FOR FURTHER INFORMATION CONTACT: 

James A. Worth, Office of the General 

Counsel, U.S. International Trade 

Commission, 500 E Street, SW., 

Washington, DC 20436, telephone (202) 

205–3065. Copies of non-confidential 

documents filed in connection with this 

investigation are or will be available for 

inspection during official business 

hours (8:45 a.m. to 5:15 p.m.) in the 

Office of the Secretary, U.S. 

International Trade Commission, 500 E 

Street, SW., Washington, DC 20436, 

telephone (202) 205–2000. General 

information concerning the Commission 

may also be obtained by accessing its 

Internet server (http://www.usitc.gov). 

The public record for this investigation 

may be viewed on the Commission’s 

electronic docket (EDIS) at http:// 

edis.usitc.gov. Hearing-impaired 

persons are advised that information on 

this matter can be obtained by 

contacting the Commission’s TDD 

terminal on (202) 205–1810. 

SUPPLEMENTARY INFORMATION: This 

investigation was instituted on March 

31, 2008, based upon a complaint filed 

on behalf of General Electric Company 

of Fairfield, Connecticut (‘‘GE’’) on 

February 7, 2008. 73 FR 16910. The 

complaint alleged violations of section 

337 of the Tariff Act of 1930 (19 U.S.C. 

1337) in the importation into the United 

States, the sale for importation, and the 

sale within the United States after 

importation of certain variable speed 

wind turbines and components thereof 

that infringe claims 121–125 of U.S. 

Patent No. 5,083,039 (‘‘the ‘039 patent’’) 

and claims 1–12, 15–18, and 21–28 of 

U.S. Patent No. 6,921,985 (‘‘the ‘985 

patent’’). The complaint named as 

respondents Mitsubishi Heavy 

Industries, Ltd. of Tokyo, Japan (‘‘MHI’’); 

Mitsubishi Power Systems, Inc. of Lake 

Mary, Florida (‘‘MPSA’’); and Mitsubishi 

Heavy Industries America, Inc. of New 

York, New York (‘‘MHIA’’). On October 

8, 2008, the Commission issued notice 

of its determination not to review an 

initial determination (‘‘ID’’) (Order No. 

10) granting GE’s motion to amend its 

complaint and the notice of 

investigation to add claims 1–19 of U.S. 

Patent No. 7,321,221 (‘‘the ‘221 patent’’) 

to this investigation. 

On August 7, 2009, the ALJ issued a 

final ID finding a violation of section 

337 in this investigation. The ALJ found 

that there was a violation in the sale for 

importation, importation, or sale after 

importation by respondents MHI and 

MPSA with respect to claim 121 of the 

‘039 patent and claim 15 of the ‘985 

patent. The ALJ found that there was no 

violation with respect to these claims by 

MHIA. The ALJ also found that there 

was no violation of section 337 by any 

party with respect to claims 5, 7, and 8 

of the ‘221 patent. 

On August 24, 2009, the Commission 

received petitions and/or contingent 

petitions for review from: (1) MHI, 

MPSA, and MHIA; (2) GE; and (3) the 

Commission investigative attorney. On 

September 1, 2009, each of the parties 

filed responses thereto. 

On October 8, 2009, the Commission 

issued notice of its determination to 

review the final ID, except with respect 

to the issue of importation and the 

intent finding underlying the ALJ’s 

inequitable conduct determination. 72 

FR 52975 (Oct. 15, 2009). The 

Commission requested briefing on the 

issues on review, including certain 

specific questions, in addition to 

remedy, the public interest, and 

bonding. 

On October 23, 2009, the Commission 

issued notice of its determination to 

extend the deadline for public 

submissions on remedy, the public 

interest, and bonding to November 2, 

2009, and for all responses to all 

remedy, the public interest, and 

bonding submissions to November 9, 

2009. 

On October 22, 2009, Mitsubishi, GE, 

the IA, and Iberdrola filed submissions 

in response to the notice of review. On 

October 30, 2009, Turner Bros., LLC 

filed a submission on remedy. On 

November 2, 2009, Mitsubishi, GE, and 

the IA filed reply submissions on 

violation. On November 9, 2009, 

Mitsubishi, GE, the IA, and Iberdrola 

filed reply submissions on remedy. 

Having reviewed the final ID, the 

submissions on review, and the record, 

the Commission has determined to 

terminate the investigation with a final 

determination of no violation. A 

Commission opinion will issue shortly. 

This action is taken under the 

authority of section 337 of the Tariff Act 

of 1930, as amended (19 U.S.C. 1337), 

and under sections 210.42–.51 of the 

Commission’s Rules of Practice and 

Procedure (19 CFR 210.42–.51). 

Issued: January 8, 2010. 

By order of the Commission. 

Marilyn R. Abbott, 

Secretary to the Commission. 

[FR Doc. 2010–499 Filed 1–13–10; 8:45 am] 

BILLING CODE 7020–02–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Manufacturer of Controlled 

Substances; Notice of Registration 

By Notice dated August 21, 2009, and 

published in the Federal Register on 

September 8, 2009 (74 FR 46232), 

Alltech Associates Inc., 2051 Waukegan 

Road, Deerfield, Illinois 60015, made 

application by renewal to the Drug 

Enforcement Administration (DEA) to 

be registered as a bulk manufacturer of 

the basic classes of controlled 

substances listed in schedules I and II: 

Drug Schedule 

Methcathinone (1237) .................. I 

N-Ethylamphetamine (1475) ........ I 

N,N-Dimethylamphetamine (1480) I 

4-Methylaminorex (cis isomer) 

(1590).

I 

Alpha-ethyltryptamine (7249) ....... I 

Lysergic acid diethylamide (7315) I 

2,5-Dimethoxy-4-(n)- 

propylthiophenethylamine 

(7348).

I 

Tetrahydrocannabinols (7370) ..... I 

Mescaline (7381) .......................... I 

4-Bromo-2,5- 

dimethoxyamphetamine (7391).

I 

4-Bromo-2,5- 

dimethoxyphenethylamine 

(7392).

I 

4-Methyl-2,5- 

dimethoxyamphetamine (7395).

I 

2,5-Dimethoxyamphetamine 

(7396).

I 

2,5-Dimethoxy-4- 

ethylamphetamine (7399).

I 

3,4-Methylenedioxyamphetamine 

(7400).

I 

N-Hydroxy-3,4- 

methylenedioxyamphetamine 

(7402).

I 

3,4-Methylenedioxy-Nethylamphetamine (7404).I 

3,4- 

Methylenedioxymethamphetamine (MDMA) (7405).

I 

4-Methoxyamphetamine (7411) ... I 

Alpha-methyltryptamine (7432) .... I 

Bufotenine (7433) ......................... I 

Diethyltryptamine (7434) .............. I 

Dimethyltryptamine (7435) ........... I 

Psilocybin (7437) .......................... I 

Psilocyn (7438) ............................. I 

5-Methoxy-N,Ndiisopropyltryptamine (7439).I 

N-Ethyl-1-phenylcyclohexylamine 

(7455).

I 

1-(1-Phenylcyclohexyl)pyrrolidine 

(7458).

I 

1-Phenylcyclohexylamine (7460) I 

1-[1-(2- 

Thienyl)cyclohexyl]piperidine 

(7470).

I 

Normorphine (9313) ..................... I 

Methamphetamine (1105) ............ II 

Phencyclidine (7471) .................... II 

Phenylacetone (8501) .................. II 


pwalker on DSK8KYBLC1PROD with NOTICES
Federal Register / Vol. 75, No. 9 / Thursday, January 14, 2010 / Notices 2161 

Drug Schedule 

1-Piperidinocyclohexanecarbonitrile (8603).II 

Cocaine (9041) ............................. II 

Codeine (9050) ............................. II 

Dihydrocodeine (9120) ................. II 

Dihydromorphine (9145) ............... II 

Ecgonine (9180) ........................... II 

Meperidine intermediate-B (9233) II 

Noroxymorphone (9668) .............. II 

The company plans to manufacture 

high purity drug standards used for 

analytical application only in clinical, 

toxicological, and forensic laboratories. 

No comments or objections have been 

received. DEA has considered the 

factors in 21 U.S.C. 823(a) and 

determined that the registration of 

Alltech Associates to manufacture the 

listed basic classes of controlled 

substances is consistent with the public 

interest at this time. DEA has 

investigated Alltech Associates to 

ensure that the company’s registration is 

consistent with the public interest. The 

investigation has included inspection 

and testing of the company’s physical 

security systems, verification of the 

company’s compliance with state and 

local laws, and a review of the 

company’s background and history. 

Therefore, pursuant to 21 U.S.C. 823, 

and in accordance with 21 CFR 1301.33, 

the above named company is granted 

registration as a bulk manufacturer of 

the basic classes of controlled 

substances listed. 

Dated: January 6, 2010. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. 2010–512 Filed 1–13–10; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF LABOR 

Employee Benefits Security 

Administration 

Proposed Extension of Information 

Collection; Comment Request; 

Employee Benefit Plan Claims 

Procedures Under ERISA 

AGENCY: Employee Benefits Security 

Administration, Department of Labor. 

ACTION: Notice. 

SUMMARY: The Department of Labor (the 

Department), in accordance with the 

Paperwork Reduction Act of 1995 (PRA 

95) (44 U.S.C. 3506(c)(2)(A)), provides 

the general public and Federal agencies 

with an opportunity to comment on 

proposed and continuing collections of 

information. This helps the Department 

assess the impact of its information 

collection requirements and minimize 

the reporting burden on the public and 

the public understand the Department’s 

information collection requirements and 

provide the requested data in the 

desired format. Currently, the Employee 

Benefits Security Administration 

(EBSA) is soliciting comments on a 

proposed extension of the current 

approval of information collection 

provisions incorporated in the 

regulation pertaining to employee 

benefit plan claims procedures under 

the Employee Retirement Income 

Security Act of 1974 (ERISA). A copy of 

the information collection request (ICR) 

may be obtained by contacting the office 

listed in the ADDRESSES section of this 

notice. 

DATES: Written comments must be 

submitted on or before March 15, 2010. 

ADDRESSES: Direct all written comments 

to G. Christopher Cosby, Office of Policy 

and Research, Employee Benefits 

Security Administration, U.S. 

Department of Labor, 200 Constitution 

Avenue, NW., Room N–5647, 

Washington, DC 20210. Telephone: 

(202) 693–8410; Fax: (202) 219–4745. 

These are not toll-free numbers. 

Comments may also be submitted 

electronically to the following Internet 

e-mail address: ebsa.opr@dol.gov. 

SUPPLEMENTARY INFORMATION: 

I. Background 

Section 503 of ERISA requires each 

employee benefit plan to provide, 

pursuant to regulations promulgated by 

the Secretary of Labor, notice in writing 

to any participant or beneficiary whose 

claim for benefits under the plan has 

been denied. The notice must set forth 

the specific reasons for the denial and 

must be written in a manner calculated 

to be understood by the claimant. Plans 

must also give a participant or 

beneficiary whose claim has been 

denied a reasonable opportunity to 

obtain a full and fair review of any 

benefit claim denial by the appropriate 

named fiduciary. 

The Department issued a regulation 

pertaining to benefit claims procedures 

in 1977 and amended that regulation in 

a Notice of Final Rulemaking (NFRM) 

published on November 21, 2000 (65 FR 

70246). The regulation pertaining to 

benefit claims procedures is codified at 

29 CFR 2560.503–1. The regulation 

requires plans to establish reasonable 

claims procedures that meet specified 

standards governing the timing and 

content of notices and disclosures. 

EBSA submitted an ICR for the 

information collections in 29 CFR 

2560.503–1 to the Office of Management 

and Budget (OMB) for review and 

clearance in connection with 

publication of the NFRM, and OMB 

approved the information collections 

under OMB control number 1210–0053. 

That approval is scheduled to expire on 

April 30, 2010. After considering 

comments received in response to this 

notice, the Department intends to 

submit an ICR to OMB to request 

continuing approval. The public is not 

required to respond to an information 

collection unless it displays a valid 

control number. No change to the 

existing ICR is being proposed or made 

at this time. 

II. Desired Focus of Comments 

The Department of Labor 

(Department) is particularly interested 

in comments that 

• Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

• Evaluate the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

• Enhance the quality, utility, and 

clarity of the information to be 

collected; and 

• Minimize the burden of the 

collection of information on those who 

are to respond, including through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submissions 

of responses. 

III. Current Action 

This notice requests comments on an 

extension of OMB’s approval of the 

information collections included in 29 

CFR 2560.503–1. The Department is not 

proposing or implementing changes to 

the existing ICR at this time. A summary 

of the ICR and the current burden 

estimates follows: 

Agency: Employee Benefits Security 

Administration, Department of Labor. 

Title: Employee Benefit Plan Claims 

Procedures under ERISA. 

Type of Review: Extension of a 

currently approved collection of 

information. 

OMB Number: 1210–0053. 

Affected Public: Business or other forprofit; not-for-profit institutions. 

Respondents: 5,900,000. 

Responses: 321,000,000. 

Estimated Total Burden Hours: 

529,000. 


pwalker on DSK8KYBLC1PROD with NOTICES